Siemens Healthineers expands radiotherapy beyond cancer, targets osteoarthritis pain
The radiotherapy systems include TrueBeam, TrueBeam STx, VitalBeam, and Edge
The radiotherapy systems include TrueBeam, TrueBeam STx, VitalBeam, and Edge
New targeted pill offers hope for adults and teens with moderate-to-severe plaque psoriasis
The once-weekly treatment targets Type 2 Diabetes Mellitus (T2DM) with demonstrated efficacy and safety
FGFR alterations are prevalent in early-stage bladder cancer, appearing in roughly 70% of intermediate-risk and 40% of high-risk NMIBC tumors
The trial enrolled patients with stage IV pancreatic cancer, where median life expectancy is just 6 to 12 months
Neupharma gains exclusive rights to develop and commercialize corticorelin for peritumoral brain edema
The Phase 1 dose-escalation trial enrolled 25 evaluable patients and was designed to determine the recommended dose of LYMPHIR
Indomo’s ClearPen system combines a proprietary self-injection device and microneedle with a modernized triamcinolone acetonide formulation
Subscribe To Our Newsletter & Stay Updated